EU · EudraLex Vol.4
EU GMP Part I, Chapter 5 5.30
Starting materials
Section text
For each delivery of starting material the containers should be checked for integrity of package, including tamper evident seal where relevant, and for correspondence between the delivery note, the purchase order, the supplier’s labels and approved manufacturer and supplier information maintained by the medicinal product manufacturer. The receiving checks on each delivery should be documented.
Footnotes and source notes
- 1 Specific requirements apply to the importation of active substances to be used in the manufacture of medicinal products for human use in article 46b of Directive 2001/83/EC.
Source: European Commission, DG SANTE · © European Union. Reuse is authorised provided the source is acknowledged (Commission Decision 2011/833/EU on the reuse of Commission documents). · retrieved 2026-11-15